Currently out of the existing stock ratings of Sebastian Sandler, 3 are a BUY (100%).
Analyst Sebastian Sandler, currently employed at JPMORGAN, has had 100% of price targets met with an average potential upside of 24.84%, reached in 65 days on average.
Sebastian Sandler has documented 6 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ADPT, Adaptive Biotechnologies Corp at 06-May-2026.
Analyst best performing recommendations are on ADPT (ADAPTIVE BIOTECHNOLOGIES CORP).
The best stock recommendation documented was for ADPT (ADAPTIVE BIOTECHNOLOGIES CORP) on 10/13/2025. The price target of $17 was fulfilled within 2 days with a profit of $1.5 (9.68%), with a performance score of 48.39.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Sep-2025
$34
$4.96 (17.08%)
$32
6 days ago
(10-Nov-2026)
Buy Since 07-Oct-2020
$34
$4.96 (17.08%)
$25
1 months 25 days ago
(22-Sep-2026)
18/22 (81.82%)
$5.94 (21.17%)
247
Buy Since 08-May-2023
$27.5
$-1.54 (-5.30%)
$20
3 months 12 days ago
(04-Aug-2026)
15/15 (100%)
$2.95 (12.02%)
359
Buy Since 06-Aug-2025
$28
$-1.04 (-3.58%)
$21
3 months 17 days ago
(30-Jul-2026)
4/4 (100%)
$3.82 (15.80%)
78
Hold Since 09-Sep-2020
$18
$-2.96 (-14.12%)
$11
6 months 4 days ago
(12-May-2026)
12/16 (75%)
$4.37 (32.06%)
517
What Year was the first public recommendation made by Sebastian Sandler?